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Abstract 
Our recent study has evaluated the ethyl acetate fraction of Gynura 
procumbens (FEG) as co-chemotherapeutic agent in combination with 5-
fluorouracil (5-FU) and cisplatin (CISP) against WiDr colon cancer cells. 
This study aimed to assess whether FEG produced synergistic effect with 5-
FU and CISP and to evaluate its regulation on proliferation, cell cycle, and 
cell death induction on WiDr colon cancer cells.  
(3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyltetrazolium bromide) MTT 
assay was performed to determine the growth inhibitory effect of both single 
(FEG, 5-FU, or CISP) and combination treatments. FEG (25-500 μg/mL),  5-
FU (25-1000 μM)  and CISP (5-100 μM) inhibited cells growth in a dose 
dependent manner and exhibited an IC50  value of 125  μg/mL, 848 M and 
43 M, respectively. FEG sensitized WiDr cells that was treated by 5-FU, 
boosting its therapeutic potential. Conversely when FEG was combined with 
CISP, it caused antagonism.  The antiproliferative effect of single and 
combination treatment was determined by studying the cell proliferation 
kinetics using MTT assay. Flowcytometry and (4’,6-diamidino-2-
phenylindole) DAPI staining was used to disclose the mechanism of cell 
cycle arrest and apoptosis. FEG inhibited cell proliferation, induced G1 and S 
phase arrest and apoptosis. The inhibitory effect was enhanced when FEG 
was combined with 5-FU, differing from CISP.  
According to the datas obtained, FEG possess sensitizing properties causes 
cell cycle arrest and cell death suppose to be apoptosis on WiDr cells. FEG 
demonstrates a possibility of additive to synergism properties when 
combined with 5-FU but shows antagonis with CISP.  
Keywords: Gynura procumbens; WiDr; G1 and S phase arrest; apoptosis. 
INTRODUCTION 
G. procumbens is a medicinal plant found 
througout South-East Asia, especially in 
Indonesia, Malaysia and Thailand. The plant has 
been traditonally used for treatment of several 
diseases such as fever, rash, kidney disease, 
migrains, constipation, hypertension, diabetes 
mellitus and cancer 1. Previous studies show 
several pharmacological properties of this plant 
such as anti-inflammatory and reduced blood 
pressure 2-3. G. procumbens extract and its 
fractions exhibit high antioxidant properties 
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shown by xantine oxidase inhibition and radical 
scavenging activity 4. The uncontrolled 
production of radical oxygen species (ROS) and 
unbalance antioxidant protective system have an 
important part on cancer initiation and 
development. These natural antioxidants may 
become a beneficial agent to be developed as 
chemoprevention substance for cancer disease.  
 Recent studies on cancer prevention and therapy 
show G. procumbens’s chemo-preventive 
properties to inhibit tumor development on 
benzo(a) pyren-treated mice and breast cancer on 
DMBA-treated rat 5-6. G. procumbens  
ethanolic extract was reported for its 
antimutagenic property against lung cancer on 
benzo(a)pyren-treated mice. Its phenolic fraction 
suppresses cell proliferation and induces 
apoptosis on HeLa cells 7. It also has an 
antiangiogenesis potency 8. G. procumbens 
decreased COX-2 expression and increased p53 
and Bax expression on breast cancer cells. Co-
chemotherapeutic study of ethyl acetate fraction 
of G. procumbens (FEG) showed the sinergism 
effect of its combination with doxorubicin on 
T47D and MCF-7 breast cancer cell lines 9. 
Aqueous extract of G. procumbens  inhibited cell 
proliferation and DNA synthesis on human 
mesangial cells 10. Sugiyanto et al. (2003) 
found flavon/flavonol as active compounds of G. 
procumbens ethanolic extract. G. procumbens 
may contain β-sitosterol and stigmasterol, 
kaempferol-3-O-Rutinoside, and quercetin 11,4. 
Proposed mechanism of G. procumbens should 
be through several way, such as block on 
carcinogenesis and suppresss cell proliferation 
through cell cycle arrest and apoptosis induction. 
Both of mechanism are suggested by its phenolic 
and flavonoid mostly contained in FEG.  
Cancer disease develops into serious problem of 
health because of its prevalency increasing year 
by year. World Health Organisasion (WHO), 
reported more than 10 millions cancer cases 
every year in the world. At Amerika, colorectal 
cancer is the third most common cancer in both 
men and women and is estimated 106,100 cases 
of colon and 40,870 cases of rectal cancer are 
expected to occur in 2009. An estimated 49,920 
deaths from colorectal cancer are expected to 
occur in 2009, accounting for almost 9% of all 
cancer deaths 12.  Despite advances in the 
management of this condition, including 
improved surgical techniques, the use of chemo- 
or radiotherapy, have not been decreased the 
mortality value for decades. These treatment 
methods are only useful for early detection cancer 
but not for metastasis stage.  Cancer treatment 
failure, especially with chemotherapy, because of 
low selectivity of the anticancer and uncertain for 
the molecular targeted. The major contributor of 
the limited effectiveness of treatment is the 
resistance of cancer cell to current 
chemotherapeutic agents. The numerous 
mechanism which contributes to chemo-
resistance include the amplification and mutation 
of drug target lead to the inhibition or avoidance 
of drug-induced apoptosis, drug transport defect 
or over expression of multi drug resistance 
protein (MRP) 13-14. In line with this problem, 
side effect rising to cancer patient inconvenience 
and further may reduce the life quality and 
productivity of patient. 
Several study report that plant constituents have 
high potency as oncogene negative regulator and 
tumor suppressor gene positive regulator that 
refer to their anticancer potency 15. Anticancer 
studies on medicinal herbs tend to focus on 
developing their potency as co-chemotherapy 
agent. These studies aim to increase cell 
sensitivity, suppress cancer cell resistance, and to 
control side effect of chemotherapy agent. 
Recent study of G. procumbens on several cancer 
cell showed high potency to be developed as 
cancer chemoprevention and co-chemotherapy. 
Study of co-chemotherapy potency of G. 
Procumbens was limited and no report found 
about the anticancer properties of this plant on 
colon cancer. Therefore it is a chance to conduct 
the advanced study of it and examined of its 
molecular mechanisms. Our study was carried out 
to elucidate the anticancer of G. procumbens on 
colon cancer cell and to observe its co-
chemotherapy effectiveness. 
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Material and Methods 
Chemicals and Reagents 
5-Fluorouracil (5-FU) (Ebewe) was purchased 
from PT. Ferron Par Pharmaceutical Cikarang, 
Indonesia. Material were used in this study: 
Cisplatin (CISP) (Kimia Farma), DMEM 
(Nacalay, Japan), Fetal Bovine Serum (FBS) 
(PAA), Dimethyl sulfoxide (DMSO) (Sigma, 
Aldrich, Germany), penicillin and streptomycin 
(Gibco), tripsin (Sigma), 3-(4,5-dimethyltiazol-2-
il)-2,5-diphenyltetrazolium bromide (MTT),  
sodium dodecyl sulphate (SDS). Tris–HCl, triton 
X-100, propidium iodide (PI), RNaseA (Sigma) 
petroleum ether, ethanol, and ethyl acetate, and 
fraction of ethyl acetate G. procumbens (FEG). 
The fractions was dissolved in DMSO with 0,1 % 
as maximum concentration.  
Human colon cancer cell lines 
Human colon cancer WiDr was kindly provided 
by Prof. Masashi Kawaichi, Nara Institute 
Science and Technology (NAIST). The cells were 
routinely grown in DMEM containing 10% FBS, 
1 % Penicillin-streptomycin (v/v), and L-
glutamine (1 mM) at 37 oC and 5% CO2.  
Plant material 
The leaves of G. Procumbens were collected by 
Balai Penelitian dan Pengembangan Tanaman 
Obat dan Obat Tradisional (BP2TO2T) 
Indonesia, and was determined at Laboratorium 
of Pharmacognocy, Faculty of Pharmacy Gadjah 
Mada University, Indonesia. Dried powdered 
leaves were first extracted with ethanol 96 %, and 
concentrated by evaporation under reduced 
pressure and the temperature was kept not more 
than 40oC.  The extract was diluted in hot water 
and then fractionated with n-hexane. The aqueous 
fraction than was fractionated again with ethyl 
acetate. The ethyl acetate fraction was 
concentrated by evaporation under reduced 
pressure and the temperature was kept not more 
than 40oC.  The extract was stored at 4oC prior to 
use.   
Cytotoxicity and co-chemotherapy 
assessments 
WiDr cells (104 cells/well) were seeded to 96-
well plate (100 uL/well). After 24 hours growth, 
cells culture medium was discarded and replaced 
with 5-FU, CISP, and/or FEG-contained medium, 
as single and combination treatment. After 
incubated for 24 hours, the medium was 
discarded and replaced with MTT-containing 
medium (0,5 mg/mL) and incubated for 4 hours 
at 37oC, 5 % CO2. The reaction was stopped with 
10% SDS in 0,1 N HCl solution and was 
incubated for overnight in light protected 
chamber, to dissolve formasan salt. The 
absorbance of each well was measured with 
ELISA reader at 595 nm. The ratio between 
treated and control cells absorbance refer to 
percentage (%) of viable cells.  
Calculation of combination effects 
The cell response from treatment with 
chemotherapy agent as a single agent was 
compared with its response treated with G.  
procumbens combination to obtain the 
combination index (CI).  
CI= D1/Dx1 + D2/Dx2 
Where, 
D1, D2 = concentration of each agent that used in 
combination  
Dx1, Dx1  = the concentration of single compound 
single compound producing the same effect with 
combination treatment (Reynolds and Maurer, 
2005). CI value interpretation: < 0.1 very strong 
synergism, 0.1–0.3 strong synergism, 0.3–0.7 
synergism, 0.7–0.9 mild to moderate synergism, 
0.9–1.1 almost additive, 1.1–1.45 mild to 
moderate antagonism, 1.45–3.3 antagonism, >3.3 
strong to very strong antagonism 
Cell proliferation assay 
The WiDr cells (3.103cells/well) were seeded in 
96-well plate and treated with the indicated 
concentrations of FEG or combined treatment 
with chemotherapy agent (5-FU and CISP). 
Control cells were supplemented with complete 
media containing maximum 0.5% dimethyl 
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sulfoxide (DMSO) (vehicle control) for 12, 24, 
48, and 72 h. Following treatment, cell number 
and viability were determined by MTT assays.  
Cell cycle analysis 
The WiDr cells (5.105 cells/well) were seeded in 
6-well plate and were treated as indicated 
concentration after 24 hours growth. After 24 
hours treatment, all cells were recovered (both 
attached and detached cells) using 0.025% 
tripsin. The cell were washed with cold PBS  and 
fixed in cold 70% ethanol (-20oC) carefully. The 
fixed cells were washed twice with PBS and 
incubated with PBS containing PI (50 μg/mL), 
RNaseA (100 μg/mL), and tritonX-100 for 30 
minutes at 37oC. The mixture solution was 
analyzed using flowcyctometer. The percentage 
of cells was determined based on DNA contents 
using ModFit Lt. 3.0 to quantified cell 
distribution on each stage of cell cycle. 
 
Results  
Inhibitory effect of 5-FU, Cisp, and FEG on 
growth of WiDr cells. 
To determine the potency of FEG as co-
chemotherapeutic agent, first the cytotoxicity 
properties were examined in WiDr colon cancer 
cell line. Cell viability was examined using MTT 
reagent after 24 hours incubation incubation. 5-
FU (50-1000 uM), Cisp (5-100 uM), and FEG 
(25-500 uM) inhibited the growth of WiDr cells 
in dose dependent manner with IC50 value of  848 
uM, 43 uM, and 125 ug/mL, respectively. (Figure 
1A and 1B)). FEG had high potency as cytotoxic 
agent on WiDr cell. This cell was more sensitive 
to CISP rather than 5-FU shown by IC50 value 
(Table 1). The combination treatment of FEG and 
5-FU or CISP was intended to improve the 
chemotherapeutic agent potency. 
Combined treatment with 5-FU+FEG resulted 
additive to synergism effect on WiDr cells 
growth inhibition but produced antagonism 
effect with Cisp+FEG combination.  
We used sub-toxic concentration both of 
chemotherapy agent (5-FU or CISP) and FEG to 
determine the combination effect on WiDr cells 
viability. FEG enhanced the inhibitory effect of 
5-FU on WiDr cells viability within 24 hours, but 
gave no enhancement effect when combined with 
CISP. The calculation of Combination Index (CI) 
showed that the combination of 5-FU and FEG 
exhibited additive to slight synergism effect on 
WiDr cells (CI value 0,2–1,1), but seemed 
antagonism after combination treatment of Cisp 
and FEG (CI value > 1,1). The cells morphology 
was changed after 24 hours treatment by sample 
as single or combination. The combination 
treatment of 5-FU and FEG show more extensive 
morphologically changes compared with single 
treatment, but this phenomenon did not show 
after combination treatment of CISP and FEG. 
FEG with sub-toxic concentration (100 ug/mL) 
suppressed cell proliferation after 24 hours 
incubation and enhanced the inhibition of cell 
proliferation of 5-FU. But when FEG combined 
with CISP failed to produce higher on the 
suppression of cell proliferation and resulted 
antagonistic effect (Figure 2A and B). This result 
proposed that FEG enhanced the cytotoxcic effect 
of 5-FU and cell proliferation inhibition. The 
suppression of cell growth could be occurred 
through cell death induction and cell cycle 
modulation.  
 
Table 1. The cytotoxicity effect on WiDr cells after 
treatment of FEG, 5-FU, and Cisp for 24 hours 
Sample/compounds IC50* 
FEG          125    ug/mL 
5-FU          848       uM 
Cisp          43         uM 
 *IC50 value as average from two independent experiment 
with the consistent result 
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Figure 1. The FEG, Dox and Cisp inhibit WiDr cell growth in dose dependent manner and FEG 
produced additive to synergistic effect when combined with 5-FU but not with Cisp on WiDr cells. 
(A, B, and C) WiDr cell viability  was determined by MTT assay after treated with the various 
concentration of FEG, Dox, or Cisp for 24 hours incubation. (D and E) The cell viability  was 
determined by MTT assay treated with the indicated concentration of 5-FU+FEG or Cisp+FEG for 
24 hours incubation. The combination index (CI) were calculated to determine the combination 
effect. The results are from one reprentative data of three experiment that showed similar results. 
Each point represents the mean ± SD of three experiments. 
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Figure 2. Combined treatment between 5-FU+FEG suppressed cell proliferation on WiDr and 
caused morphological changing (A and B) The cell proliferation was examined with cell viability 
measurement using MTT assay after treated with indicated concentration of FEG, 5-FU, Cisp, and 
combination between 5-FU+FEG or Cisp+FEG for 0, 12, 24, 48, 72 hours. The combination of 5-
FU+FEG suppressed the cell growth but not with Cisp+FEG. (C) The cellular morphology of the 
cells was examined under inverted microscope (x 400). The results are from one reprentative data of 
three experiment that showed similar results. Each point represents the mean ± SD of three 
experiments. 
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Figure 3. The combined treatment with Dox/5-FU and FEG induced nuclear shrinkage and 
chromatin condensation on WiDr cells. A. The cells were treated with the indicated concentration of 
5-FU, FEG, or 5-FU+FEG for 24 hs. The cells fixed with cold methanol and stained with DAPI and 
quantified for percentage of condensed nuclei. B. To determine whether all treatment caused the 
morphological changing, the cells morphology was examined under fluorescence microscope with 
400x in magnification. 
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Figure 4. The effect of 5-FU and FEG on cell cycle progression. (A and B) The cells were treated with 
the indicated concentration 5-FU and FEG, then analyzed by flowcytometry. 5-FU caused S phase 
arrest after 24 hs incubation in dose dependent manner, while FEG produced G1 arrest. The results 
are from one reprentative data of two experiment that showed similar results.  
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Figure 5.  The 5-FU+FEG resulted G1 and S phase arrest and produced synergistic effect on sub-G1 
accumulation. The cells were treated with the indicated concentration of Dox, 5-FU, FEG, or 5-FU+FEG  for 
24 hs. (A and B) The DNA content was analyzed by flowcytometry. The observed effect of sub-G1 induction 
shows higher when compared with the sum of single one and to the effect of 5-FU alone. The results are from 
one reprentative data of two experiment that showed similar results. 
 
 
Table 2. The cell cycle distribution on WiDr cells after treatment of 5-FU, FEG and their combination for 24 
hours 
Treatment Percentage (%) 
G1-phase S-phase G2/M-phase 
DMSO 49.86 33.68 16.47
FEG 100 g/mL 53.24 30.95 15.81 
FEG 200 g/mL 56.32 25.68 18.01 
5-FU 500 M 57.66 41.99 0.35 
5-FU -FEG  
(500 M -100 g/mL) 
54.57 45.43 0.00 
5-FU-FEG  
(500 M -200 g/mL) 
55.36 43.02 1.62 
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The combined treatment with 5-FU+FEG 
induced nuclear shrinkage and chromatin 
condensation on WiDr cells 
For further investigation on cell death induction, 
we predominantly focused on the combined 
treatment of 5-FU and FEG compare with single 
treatment. The morphological examinations of 
WiDr cells showed the difference between the 
treated groups and the control. after the single 
treatment of 5-FU, CISP, or FEG, cells were 
detached from the surface and contained some 
debris, whereas the control group was well 
spreaded with a normal morphology. The 
chromatin condensation and membrane shrinkage 
were showed at WiDr cells after treated by single 
treatment of 5-FU and FEG while at control cell 
(DMSO) no condensed nuclei found. The 
chromatin condensation, membrane shrinkage, 
and also nuclear fragmented were showed 
extensively after cell treated by combined 
treatment of 5-FU and FEG.  These phenomenon 
especially nuclear fragmented indicated the DNA 
fragmentation and nuclear membrane damage as 
one of main indicators for late apoptosis (Figure 
3). All the result suggested that FEG increased 5-
FU-induce cell death. Chromatin condensation, 
membrane shrinkage and nuclear fragmented 
addressed to apoptosis cell death. 
The FEG resulted additive to synergism effect 
on sub-G1 accumulation when combined with 
5-FU and also resulted G1 and S phase arrest. 
To determine whether the anti-proliferative 
activity of FEG as a single or combination 
treatment with 5-FU would lead to cell cycle 
arrest and cell death, we analyzed the cell cycle 
distribution of WiDr cells using fluorescence-
activated cell sorting (FACS). FEG treatment 
alone caused on sub-G1 accumulation referred to 
cell death induction trough apoptosis or necrosis. 
FEG modulated cell cycle progression resulting 
G1 phase arrest in dose dependent manner 
(Figure 4A). 5-FU treatment exhibited very 
significance cell cycle arrest both on G1 and S 
phase, but just produced a slight sub-G1 
accumulation (Figure 4B). Combined treatment 
of 5-FU and FEG exhibited higher accumulation 
on sub-G1 measurement if compared with single 
one (both FEG and 5-FU). This combination also 
caused both G1 and S phase arrest. The 
combination treatment mainly produced strong 
inhibition on S phase (Figure 5A). As we know 
that 5-FU already well-known as a DNA 
synthesis inhibitor could lead both of G1 or S 
phase arrest at cell cycle progression. Co-
treatment with FEG enhanced this effect shown 
by the increasing of S phase measurement (Table 
2). Combined treatment also caused increasing of 
cell death induction shown by sub-G1 
measurement (Figure 5B). Thus, FEG  
augmented 5-FU-modulated cell cycle shown by 
G1 and S phase arrest. The increasing of sub G1 
accumulation refered to cell death induction.  
Discussion 
WiDr colon cancer cell line, has molecular 
characteristic with mutated p53. Tumor cells with 
p53 mutant have less respond to apoptosis-
induced agent and cell become resistant to DNA 
damage and apoptosis as target. For long-term 
usage chemotherapy agent, cancer cell become 
resistance to several chemotherapy agent. 
Development of drug resistance in human tumor 
is primary cause of the failure of chemotherapy.  
The extract and fraction of G. procumbens 
represented many flavonoid compound as 
identified as flavon/flavonol 5. Previous study 
of G. procumbens has many pharmacological 
effects supporting its anticancer properties. G. 
procumbens extract and fraction exhibited high 
antioxidant shown by xantine oxidase inhibition 
and radical scavenging activity 4. Since 
uncontrolled cellular ROS production and 
unbalanced antioxidant protective have important 
part on cancer development, chemoprevention 
and co-chemotherapy using G. procumbens may 
support colon cancer treatment with its resistance 
problem without higher side effect risk.  
The 5-FU, Cisp, or FEG treatment on WiDr cells 
caused cell growth inhibition and morphological 
changing in dose dependent manner. The result of 
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cytotoxic assay exhibited more sensitive to CISP 
compared to 5-FU on WiDr cell, as shown by 
IC50 value (1/10 IC50 5-FU). The long expose of 
5-FU as establish chemotherapy for colon cancer 
was known to lead colon cancer resistance 16. 
5-FU and CISP are chemotherapy agent for colon 
cancer as single and combination usage with 
other chemotherapy agent. 5-FU has spesifik 
target on DNA synthesis while CISP could be 
intercalated with DNA and lead to DNA damage.  
Combined treatment of 5-FU and FEG produced 
additive to slight synergistic effect on cell growth 
inhibition at sub-toxic concentration on WiDr 
cells. The usage of G. procumbens as co-
chemotherapy agent sensitized cancer cells 
therefore at sub-toxic concentration 5-FU resulted 
higher effect than that of single one at toxic 
concentration. Meanwhile combined treatment 
Cisp+FEG resulted to antagonistic effect as 
shown by high value as CI (CI> 1,1). 
Combination treatment of 5-FU and FEG caused 
morphological changes more extensive compare 
to single treatment. Opposited with that 
phenomenon, combination treatment of CISP and 
FEG gave no effect on cell morphology 
compared with control. Combination treatment of 
5-FU and FEG also produced inhibition effect on 
cell proliferation higher than single one. 
Conversely, CISP and FEG treatment exhibited 
lower effect than 5-FU as single one. We 
determined the antiproliferative potential of 5-
FU, CISP, and FEG as single and combination 
treatment on WiDr cells. In parallel with previous 
cytotoxic effect as combination treatment, just 5-
FU and FEG combined treatment produced 
stronger inhibition on cell growth and 
proliferation.  
WiDr cells were proved more resistance to 5-FU 
than that to CISP, shown by higher IC50 value. 
The long usage of 5-FU lead to colon cancer 
resistance with the increasing BCl-2 and BCl-xl 
and also suppressing the Bax level was 
determined as the marker of cells resistance 
development 16. The ethyl acetate fraction of 
G. procumbens previously resulted the increasing 
of p53 and Bax on breast cancer cells 17. Ethyl 
acetate fraction of G. procumbens may contain β-
sitosterol and stigmasterol 11. kaempferol-3-O-
Rutinoside, astragalin and quercetin 4. 
Kaempferol resulted cell growth and proliferation 
inhibition, and also increase the Bax and decrease 
BCl-2 protein level, leading to apoptotic 
induction trough mitochondria dependent 18.  
For further analysis, the nuclear cells stained with 
DAPI and PI to assessed nuclear changes that 
might be correlated with cell death phenomenon. 
5-FU and FEG as single and combination 
treatment caused morphologically changes as 
identified as chromatin condensation. Combined 
treatment with 5-FU+FEG was not only 
generated more extensive chromatin 
condensation, but also lead to nucleus 
fragmentation. Cell death induction effect also 
was shown by the increasing sub-G1 
accumulation on cell cycle analysis. The 5-
FU+FEG treatment resulted additive to slight 
synergistic effect on cell death induction. 
Chromatin condensation was one of marker for 
apoptosis. Because of WiDr cells have p53 
mutant, so apoptosis induction on WiDr cells 
may be through p53 independent. 
 The cell cycle analysis was conducted to 
determine the modulation effect of 5-FU and 
FEG as single and combined treatment on WiDr’s 
cell cycle. As reported before that kaemferol as 
one of compound may contain in FEG, caused 
significance increased in  S-phase in cell 
population on MDA-MB453 breast cancer cell 
line 19. Combination between quercetin and 
several chemotherapy agent for colon cancer, 
such as oxaliplatin, leucovorin, and 5-FU, 
increased superoxide dismutase and decreased 
BCl-2 expression through inhibition of NFκB 
activity. This combination suppressed HT29 cell 
growth and prolong survival on in vivo 
experiment 20. 5-FU and FEG as single 
treatment could modulate cell cycle. 5-FU is 
already well known as antimetabolite compound 
at DNA and RNA synthesis process. WiDr cells 
arrested at G1 and S phase after 5-FU treatment. 
Single treatment of FEG lead to G1 phase arrest, 
might cause protein synthesis inhibition at early 
phase of cell cycle. Therefore the cell will be 
accumulated at restriction point before entering S 
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phase. Combined treatment 5-FU+FEG resulted 
to accumulation G1 and S phase with dominant 
on S phase arrest. Combination treatment of 5-FU 
treatment with sub-toxic concentration produced 
higher inhibition of DNA and RNA synthesis 
than that of single one. It might be caused by 
sensitized effect of FEG to WiDr cells 
Conclusion 
The FEG as co-chemotherapy treatment with 5-
FU on WiDr cell exhibited additive to slight 
synergistic effect on proliferation inhibition and 
apoptosis induction, but Cisp and FEG treatment 
produced antagonism effect. Combined treatment 
of 5-FU and FEG arrested cell on G1 and S 
phase. This combination has potency to develop 
as combination therapy that mainly aim to reduce 
side effect and suppress resistance of 
chemotherapy agent. The extended research need 
to explore the mechanism and interaction of 
combined treatment for colon cancer.  
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